Adjustments in furosemide dose in patients with heart faillure receiving SGLT2is-does HbA1c matter?

20 May 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Maria Stratinaki

Venizelio General Hospital, Heraklion (Greece)

5 More presentations in this session

Presentation thumbnail

Impact of early initiation of mTOR inhibitors on long-term survival outcome after heart transplantation: data from the nationwide Korean Organ Transplant Registry (KOTRY)

Professor H. Cho (Seoul, KR)

Abstract Slides

Presentation thumbnail

Kidney dysfunction correlates with worse response to levosimendan treatment

Doctor F. Gerardo (Amadora, PT)

Abstract Slides

Presentation thumbnail

Baseline characteristics and alterations after initiation of therapy with SGLT2i in a real-world heart failure with reduced ejection fraction population

Doctor A. Stavrati (Thessaloniki, GR)

Abstract Slides

Presentation thumbnail

A year in the life of diuretic usage in an outpatient heart failure unit

Doctor D. O'Flynn (Dublin, IE)

Abstract Slides

Presentation thumbnail

Long-term clinical impact of nutritional intervention in patients with acute heart failure

Assistant Professor K. Choi (Seoul, KR)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - treatment 2

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources